TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Inhibition of FXIa activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Bleeding times
Endpoint domain: Adverse events/effects
Primary endpoint: SNOT-22 score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MDA (Malondialdehyde) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: TAC (Total Antioxidant Capacity) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hct (Hematocrit) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of radial artery occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: 30-day all-cause death/HF hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: 180-day all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: Costs of care
Endpoint domain: Resource use
Primary endpoint: Noticing calorie information
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accurate estimation of calories in beverages ordered
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: predicting pCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Degree of functional disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: hand-grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 4-m gait speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: decrease in neuropathic pain syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportions of vaccine hesitancy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportions of vaccine resistance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean scores for knowledge about COVID-19 vaccine
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean scores for attitude towards COVID-19 vaccine
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients receiving ITEOL
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: symptom outcomes at the end of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of undergoing cesarean section
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Requirement for postoperative opioid analgesics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: PPV (Pulse Pressure Variation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: scoliosis degree improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in abdominal fat volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in abdominal fat thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of non-ART-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: CD4/CD8 cell ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: time spent on inserting the catheters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Likelihood of axillary metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Turnover intention
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Negative coping style
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Positive coping style
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fulfillment of medical emergency team activation criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality Adjusted Life Year (QALY) gained
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: FEV1% predicted value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in chromogranin A levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood sugar levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic pressure rise response to skin incision
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety profile of oral azacitidine
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change in 5-chair rises
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in gait speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in lower limb spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-rater reliability (IRR)
Endpoint domain: Adverse events/effects
Primary endpoint: Hyperactivity/impulsivity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Oppositional behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Occurrence of seizures
Endpoint domain: Adverse events/effects
Primary endpoint: Cmax of ASP3652
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of ASP3652
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of patients with CUA lesions at month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: sitting motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attainment of multiple treatment targets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cognitive flexibility deficits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MSTS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standardized Incidence Ratio (SIR) of any second primary cancer
Endpoint domain: Mortality/survival
Primary endpoint: Wear compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity for dysplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain interference
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Inflammatory cells grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Composite outcome of fatal or nonfatal worsening
Endpoint domain: Mortality/survival
Primary endpoint: Ventilation performing skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chest compression performing skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative dose of post-operative morphine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSF opening pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidental discoveries of papilledema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: incidence of shock
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of liver insufficiency
Endpoint domain: Adverse events/effects
Primary endpoint: Progression of DKD
Endpoint domain: Mortality/survival
Primary endpoint: Thirty-second sprint performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-min mean power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Na+‐K+ β1 protein content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Resolution of dyspeptic symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Survival rate of abutments
Endpoint domain: Mortality/survival
Primary endpoint: Early recurrence within 7 days
Endpoint domain: Mortality/survival
Primary endpoint: Median progression-free survival duration
Endpoint domain: Mortality/survival
Primary endpoint: Median overall survival duration
Endpoint domain: Mortality/survival
Primary endpoint: improvement of upper limb motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic bone density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thinking about harms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Discouragement from WT smoking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Shoulder counter-rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lateral trunk flexion relative to the pelvis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAMD-24 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor blockade duration
Endpoint domain: Adverse events/effects
Primary endpoint: BCTQ questionnaires
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wrist to forearm ratio (WFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confirmed tumor response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: limb function after stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of successful responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: day 7 plasma lumefantrine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean pain ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean pain change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stigma ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: jaw pain intensity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: active pain-free mouth opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived improvements in residents' quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: tumor uptake at 4 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood pool retention at 4 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bladder accumulation at 60 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histology improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alpha-fetoprotein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASCVD events
Endpoint domain: Mortality/survival
Primary endpoint: RH-FMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Self-rating depression scale (SDS) score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage reduction in the size of the lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: successful outcome (GROC score of 5 or greater)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area of epithelial defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of healing for corneal epithelial defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FeO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FeCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroconversion rates (SCR) for Sabin and Salk serotypes 1 and 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: perioperative stroke rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Detection of in‐transit metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: inability to walk 400 m
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical-site infection
Endpoint domain: Adverse events/effects
Primary endpoint: Mobilization duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Longitudinal setup errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTV margins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuous quitting of BQ chewing for ≥6 weeks
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Frequency and amount of BQ intake at the 8th week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful procedural virtual support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Diabetes‐Specific Quality of Life Scale (DSQLS) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: glycated hemoglobin (HbA1C) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: comparative durability, efficacy and safety of metabolic surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score during nasal packing removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State Anxiety Inventory (STAI-S)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: RSS (Recovery Satisfaction Score)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: AF-specific HRQOL improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: AF symptom severity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatigue Severity Scale (FSS) score change
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: SPHERE score change
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Improvement in incremental shuttle walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kidney Disease Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Urinary excretion of liver-type fatty acid-binding protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Skin depigmentation improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: 6-month Glasgow Outcome Scale - Extended (GOSE)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Accuracy of translation movement along the x-axes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of rotation along the y-axes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of rotation along the z-axes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean absolute errors within the body
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2%/2‐mm γ passing rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute dose discrepancies within the regions of interest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child BMI at 2.5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiation dose (Air kerma)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: chair-stand capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite scores of function and fat-free mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sexual and reproductive health knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: financial literacy
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: savings behavior
Endpoint domain: Resource use
Endpoint subdomain: null
Primary endpoint: Reduction of radiation fibrosis syndrome (RFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LMD (Left Main Disease)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: hospital readmission
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in foot function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usability of iBDecide
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Urticaria activity score at 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in HAMD Item 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suicidal ideation on the C-SSRS
Endpoint domain: Adverse events/effects
Primary endpoint: overall incidence of catheter-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of arrhythmia
Endpoint domain: Adverse events/effects
Primary endpoint: ABI improvement of > 0.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TcPO2 improvement of > 15% at midfoot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal Important Differences (MIDs) in QLQ-C30
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Iodine concentration of tumor in venous phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CT-reported LN status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under curve (AUC) for prediction of LNM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of overall burnout
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: rate of depressive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: likelihood of leaving current practice
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Willingness to stop medications
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: orbital volume increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical fitting time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IUD expulsion rate at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: IUD continuation at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Handling-insufflation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients attaining ≥ 3 targets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of radiation-induced toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: progression-free intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of preterm PE
Endpoint domain: Mortality/survival
Primary endpoint: Manchester‐Oxford Foot Questionnaire Index (MOxFQ Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of HDRS-17
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coverage of root surface by hPLF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall coronary therapeutic interventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of complex PCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Area under the receiver-operating curve (AUC) for revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sural sensory nerve amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sural nerve conduction velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neuropathy deficit score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement in RBD-symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction of sleep behavior disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: OMAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean International Hip Outcome Tool (iHOT-33) score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ambulation improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes